Evaluation of a novel continuous glucose measurement device in patients with diabetes mellitus across the glycemic range

Journal of Diabetes Science and Technology

Volumn 5, Issue 4, 2011, Pages 853-859

  Morrow, Linda ^a   Hompesch, Marcus ^a   Tideman, Ann M ^b   Matson, Jennifer ^b   Dunne, Nancy ^b   Pardo, Scott ^b   Parkes, Joan L ^b   Schachner, Holly C ^b   Simmons, David A ^b  

^a Profil Institute for Clinical Research Inc   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

Blood glucose; Continuous glucose monitoring; Glucose clamp method; Hyperglycemia; Hypoglycemia

Indexed keywords

ADULT; ARTICLE; AUTOMATION; BLOOD; BLOOD GLUCOSE MONITORING; CALIBRATION; CLINICAL TRIAL; DEVICES; DIABETES MELLITUS; FEMALE; GENETIC PROCEDURES; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; INSTRUMENTATION; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; RETROSPECTIVE STUDY; STANDARD;

ADULT; AUTOMATION; BIOSENSING TECHNIQUES; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CALIBRATION; DIABETES MELLITUS; EQUIPMENT AND SUPPLIES; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84855410538     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500406     Document Type: Article

References (22)

1. Hay LC, Wilmshurst EG, Fulcher G. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring. Diabetes Technol Ther. 2003;5(1):19-26.
2. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004;27(3):734-8.
3. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231-9.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-53.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-86.
6. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001;161(13):1653-9.
7. Jacobs B, Phan K, Bertheau L, Dogbey G, Schwartz F, Shubrook J. Continuous glucose monitoring system in a rural intensive care unit: a pilot study evaluating accuracy and acceptance. J Diabetes Sci Technol. 2010;4(3):636-44.
8. McGarraugh GV, Clarke WL, Kovatchev BP. Comparison of the clinical information provided by the FreeStyle Navigator continuous interstitial glucose monitor versus traditional blood glucose readings. Diabetes Technol Ther. 2010;12(5):365-71.
9. Mazze RS, Strock E, Borgman S, Wesley D, Stout P, Racchini J. Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): Is CGM ready for real time? Diabetes Technol Ther. 2009;11(1):11-8.
10. Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther. 2000;2(3):461-72.
11. Dexcom STS-7 Continuous Glucose Monitoring System summary of safety and effectiveness data. http://www.accessdata.fda.gov/cdrh-docs/pdf5/P050012S001b. pdf. Accessed April 13, 2011.
12. Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia. 2005;48(9):1833-40.
13. Garg SK, Smith J, Beatson C, Lopez-Baca B, Voelmle M, Gottlieb PA. Comparison of accuracy and safety of the SEVEN and the Navigator continuous glucose monitoring systems. Diabetes Technol Ther. 2009;11(2):65-72.
14. Ichimori S, Nishida K, Shimoda S, Sekigami T, Matsuo Y, Ichinose K, Shichiri M, Sakakida M, Araki E. Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas. J Artif Organs. 2006;9(2):105-13.
15. Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care. 2000;23(8):1143-8.
16. Clarke WL. The original Clarke Error Grid Analysis (EGA). Diabetes Technol Ther. 2005;7(5):776-9.
17. Draize JH. Dermal toxicity. In: Staff of the Division of Pharmacology, Food and Drug Administration, Department of Health, Education and Welfare, eds. Appraisal of the safety of chemicals in foods, drugs and cosmetics. Austin: Association of Food and Drug Officials of the United States Business Office, Bureau of Food and Drugs, Texas State Department of Health; 1959, 46-59.
18. Johnson AW, Goodwin BF. The Draize test and modifications. Curr Probl Dermatol. 1985;14:31-8.
19. Hirsch IB. Clinical review: realistic expectations and practical use of continuous glucose monitoring for the endocrinologist. J Clin Endocrinol Metab. 2009;94(7):2232-8.
20. Keenan DB, Mastrototaro JJ, Voskanyan G, Steil GM. Delays in minimally invasive continuous glucose monitoring devices: a review of current technology. J Diabetes Sci Technol. 2009;3(5):1207-14.
21. Clarke WL, Anderson S, Farhy L, Breton M, Gonder-Frederick L, Cox D, Kovatchev B. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care. 2005;28(10):2412-7.
22. Zisser HC, Bailey TS, Schwartz S, Ratner RE, Wise J. Accuracy of the SEVEN continuous glucose monitoring system: comparison with frequently sampled venous glucose measurements. J Diabetes Sci Technol. 2009;3(5):1146-54.